Table 3.
Diagnostic test | Sensitivity |
---|---|
Tumor markers | |
CA19.9 | 80–90% |
CEA | 30% |
Radiology | |
Computational Tomography (CT) | 50–60% |
Magnetic Resonance Imaging (MRI) | 50–90% |
Intraductal ultrasound | 89–95% |
Endoscopy | |
Cholangiography and sampling | 45–75% |
Nuclear medicine | |
PET | 85% (18% in infiltrative CCA) |
Cytology analysis | |
Routine cytology | 16–68% |
Digital Imaging Analysis (DIA) | 44% |
Fluorescence In Situ Hybridization (FISH) | 43% |